Copy
View this email in your browser
Paulding County teen undergoes CPR
after vaping at school
 
A student at South Paulding High School in Douglasville, Georgia collapsed and nearly died last week after taking a hit from a vape pen offered by another student. London Davis took the hit, returned to the classroom, collapsed, and stopped breathing. A school nurse performed CPR after Davis’ heart reportedly stopped beating.
 
London and his mother, Emily Woodall, said they wanted to be open about this because a few hits from a dab pen nearly ended London’s life.
 
She said she called the principal as she rushed to the school. He told her, “I am standing outside of the school, putting your son into an ambulance right now, and it’s bad,” she said. “They’ve never seen anything like this. They don’t believe it was just THC.”
 
London said vape pens and dab pens that contain THC concentrates are fairly common. It is not clear whether the student who handed London the dab pen will face any consequences.
 
The Paulding County School District released a statement to Fox News saying that vaping has reached near-epidemic proportions among high school students, middle-school students, and even some elementary school students, not just in its system but among teenagers across the nation.
 
It notes that its school system in collaboration with the Paulding County Sheriff’s office has been holding alcohol and drug awareness programs for students all year. In the coming days, the school district will send letters and resources to educate parents so they can have conversations with their children about the serious nature of this problem, noting that vaping is illegal for those under age 18 and is against school rules. In order to be effective, the statement says, schools must involve parents in the solution.
 
Read Fox News story here.

 
Health professionals wary of medicinal cannabis misuse and adverse effects
 
Researchers at Queensland University of Technology in Australia (Gardens Point campus pictured above), analyzed several studies. Science Daily summarizes this analysis with the following key points:
  • “26 published studies conducted in Australia, the United States, Canada, Ireland, and internationally were analyzed.
  • “These studies assessed the beliefs, knowledge, and concerns about medicinal cannabis held by medical practitioners, nurses, pharmacists, and allied health professionals.
  • “Generally, health professionals supported clinical use of medicinal cannabis, however they said they lacked knowledge across all aspects, from pharmacology and dosing to legislation around access, distribution, and supply.
  • “Their greatest concerns about the drug were patient harm, adverse drug interactions, and whether cannabis would be obtained 'medicinally' as a legal guise for recreational use.”
Read Science Daily full account of this analysis here.
Read full text of the Queensland University study here.

 
Image by Steve Buissinne from Pixabay
Denver says no to ‘magic mushrooms’:
Historic vote on psilocybin unlikely to pass
 
Decriminalize Denver is an advocacy group that sponsored a voter ballot initiative in Denver, Colorado to decriminalize the use and possession of psilocybin mushrooms.
 
Proponents had promoted the ballot initiative as an alternative treatment for opioid addiction and mental health troubles. Measure 301 was on track to fail at 1:15 a.m. ET this morning by a vote of 46.5 percent in favor and 54.5 percent opposed. The measure was the first in the nation to mirror the playbook for legalizing a controlled psychoactive drug other than marijuana.
 
Petition signers “said they are tired of seeing people going to jail over what they choose to put in their body,” says Kevin Matthews, campaign director of Decriminalize Denver. But City District Attorney Beth McCann pointed out that only 11 of more than 9,000 drug cases between 2016 and 2018 involved psilocybin. Three of those were for distribution.
 
Read USA Today story here.

 
CBD content in vaporized cannabis
does not prevent THC-induced impairment
of driving and cognition
 
Many people believe that CBD, a non-psychoactive marijuana component, mitigates the effects of THC, the marijuana component primarily responsible for intoxication.
 
This study compared the effects of THC-dominant and THC/CBD equivalent marijuana on simulated driving and cognitive performance.
 
Fourteen healthy volunteers who used marijuana occasionally participated in the randomized, double-blind study. Their simulated driving and cognitive performance was tested between 20 to 60 minutes and again between 200 to 240 minutes after vaporizing one of the following: 
  • THC-dominant marijuana (11% THC and less than 1% CBD)
  • THC/CBD equivalent marijuana (11% THC and 11% CBD)
  • Placebo marijuana (less than 1% THC and less than 1% CBD) 
Both THC-dominant and THC/CBD equivalent marijuana increased lane-weaving during a car-following task and impaired three cognitive tasks. Peak plasma THC concentrations were higher following THC/CBD equivalent marijuana than THC-dominant marijuana, “suggesting a possible pharmacokinetic interaction,” note the researchers.
 
They conclude, “Cannabis containing equivalent concentrations of CBD and THC appears no less impairing that THC-dominant cannabis, and in some circumstances, CBD may actually exacerbate THC-induced impairment.”
 
The study by Thomas R. Arkell and colleagues appears in Psychopharmacology. Read full text here.

 
Research links adolescent substance use
to adult brain volumes
 
This study by Dr. Michael Windle of Emory University and colleagues from other institutions reveals associations between nicotine, alcohol, and marijuana use during two periods of adolescence and smaller gray matter volume in two brain areas at age 25. Dr. Wilde gave the National Institute on Drug Abuse permission to use the data from this study to create the graphic above.
 
The study finds that substance use in early adolescence (ages 13-15) was associated with significantly smaller volumes in the left and right amygdala, which are involved in emotional processing, at age 25. Substance use in middle adolescence (ages 16-18) was associated with significantly reduced volume in the left pars opercularis, which is involved in cognitive control.
 
Titled “Age sensitive associations of adolescent substance use with amygdalar, ventral striatum, and frontal volumes in young adulthood” and supported by a grant from the National Institutes of Health, the study appears in Drug and Alcohol Dependence.
 
Read the National Institute on Drug Abuse’s account of the study here.

 
Short Takes
 
First-time marijuana use doubles in Canada after legalization
A new report from the Canadian government finds that 646,000 Canadians tried marijuana for the first time between January and March 2019, nearly double the 327,000 who did so during the first quarter of 2018 before legalization.
Read story here
 

Oklahoma approves astonishing number of applications for industry growing, processing, and selling marijuana for medical use
As of May 6, 2019, the Oklahoma Medical Marijuana Authority reports that applications have been approved for 108,696 patients, 1,398 caregivers, 2,819 growers, 1,445 dispensaries, and 782 processors for a total of 115,140 licensees – all in ten months. The state legalized marijuana for medical use effective June 26, 2018, and the ballot initiative became effective one month later.
Read story here.
Visit The Marijuana Report’s Facebook page
In addition to four issues of The Marijuana Report itself, we are posting several more marijuana messages each month on our Facebook page. Search Facebook for nationalfamilies to access it.

The Marijuana Report is a weekly e-newsletter published by National Families in Action in partnership with SAM (Smart Approaches to Marijuana).

Visit National Families in Action's website, The Marijuana Report.Org, to learn more about the marijuana story unfolding across the nation.

Subscribe to The Marijuana Report e-newsletter.


The Marijuana Report Staff
Executive Editor
Sue Rusche
Editor
Nicole Carter
IT Consultant
Lee Clontz
Social Media Coordinator
Margarita Eberline
 
We are grateful to our Board of Directors and Senior Adviser for their support of National Families in Action, which produces The Marijuana Report website and e-newsletter.
 
National Families in Action
Board of Directors

William F. Carter, Chairman of the Board
Realtor Berkshire Hathaway HomeServices – Georgia Properties, Atlanta.

Sue Rusche, President and CEO, Atlanta.

Richard L. Brown, Secretary
Attorney (Ret.), Lakewood Ranch, Florida
Founder & Chairman, Sudden Cardiac Arrest Association 

Jeannine F. Adams, Director
President and CEO, J. Addams & Partners, Atlanta.

Jack L. Arbiser, MD, PhD, Director
Thomas J. Lawley Professor of Dermatology
Winship Cancer Institute, Emory University, Atlanta

William H. Avery, Director
Partner (Ret.), Alston & Bird, LLP, Atlanta.

Margarita Eberline, Director
Strategy Director, 360 Marketing Plus, Atlanta.

Robert Margolis, PhD, Director
Founder, Caron Solutions Intensive Outpatient Program, Roswell, Georgia.

Shannon Murphy, MD FAAP, Director
Birmingham, Alabama 
 
Senior Adviser
Kent “Oz” Nelson, Chairman and CEO (Ret.)
United Parcel Service, Atlanta.
 
National Families
National Families
National Families
The MJ Report
The MJ Report
The MJ Report
SAM
SAM
SAM

Note: If someone forwarded this to you, please do not unsubscribe. Clicking the Unsubscribe button will end that person's subscription. Instead, please ask the person who forwarded this to you to take you off his or her forwarding list. Thank you!
Copyright © 2019 National Families in Action, All rights reserved.


unsubscribe from this list    update subscription preferences